Berlex Yasmin TV Ad Cited By FDA Following Release In Test Markets
Executive Summary
FDA is citing a television ad for Berlex's oral contraceptive Yasmin that recently concluded its run in test markets
You may also be interested in...
Berlex To Submit Angeliq NDA Response In March, Add Cardioprotective Data
Schering AG's Berlex subsidiary expects to complete its response to FDA on its NDA for the hormone replacement therapy Angeliq in March
Berlex To Submit Angeliq NDA Response In March, Add Cardioprotective Data
Schering AG's Berlex subsidiary expects to complete its response to FDA on its NDA for the hormone replacement therapy Angeliq in March
FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs
FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns